It may be a wise decision. My point was two folder; NH was wrong in comparing generics to bread crumbs both because it is negative to do so and secondly that generics are increasing in price especially where competition is limited. Secondly, he also put generics aside; to me dual intensity should have been maintain to ensure more generic revenue instead of relying heavily on shares (dilution). Yes ELTP would be much higher today if not for the dilution. One thing is to dilute and another is to minimize revenue streams as a trade-of to ART.
News 
Market Data 
Discover 
